Home  |  Contact

UniProtKB/Swiss-Prot B0I1T2: Variant p.Gln861Arg

Unconventional myosin-Ig
Gene: MYO1G
Variant information

Variant position:  861
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glutamine (Q) to Arginine (R) at position 861 (Q861R, p.Gln861Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (Q) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  861
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1018
The length of the canonical sequence.

Location on the sequence:   SSATDNPTASSLFAQRLKTL  Q DKDGFGAVLFSSHVRKVNRF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SSATDNPTASSLFAQRLKTLQDKDGFGAVLFSSHVRKVNRF

Mouse                         SSDTDNPTASHLFAEQLKALREKDGFGSVLFSSHVRKVNRF

Chicken                       SSASENPGLALPFAHRVQALRDKVHFGAVLFSSHVRKINRF

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1018 Unconventional myosin-Ig
Domain 824 – 1017 TH1
Alternative sequence 231 – 1018 Missing. In isoform 2.
Alternative sequence 526 – 1018 Missing. In isoform 3.
Alternative sequence 723 – 1018 Missing. In isoform 4.
Mutagenesis 876 – 876 R -> A. No effect on membrane localization.
Mutagenesis 880 – 880 R -> A. No effect on membrane localization.


Literature citations

Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free recombination: preparation of full-length cDNA clones encoding motor proteins.
Yamakawa H.; Kikuno R.F.; Nagase T.; Ohara O.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANTS THR-489 AND ARG-861;

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 723-1018 (ISOFORM 1); VARIANT ARG-861;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.